Q1 met expectations, but the guidance downgrade was a surprise
08/05/25 -"Demant’s Q1 results met market expectations. Growth in Hearing Care was counterbalanced by weakness in Hearing Aids. Meanwhile, Diagnostics remained stable. However, profitability fell short of ..."
Pages
63
Language
English
Published on
08/05/25
You may also be interested by these reports :
05/12/25
In addition to revising our estimates downwards to address near-term challenges, we have also injected a 20% discount into peer-based valuation ...
05/12/25
On the back of promising operating results, which also prompted management to upgrade its guidance, our estimates reset higher. This is commendable, ...
05/12/25
We have incorporated the actual figures for the FY24/25 ending in June 2025. While the recurring EBIT was in line with our forecast (€44.2m vs ...
03/12/25
Despite challenges that have reduced our target price, Demant still presents a significant upside. The company is poised to benefit from: 1) new ...